Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

NovaBay Pharmaceuticals (NBY) Shares Outstanding (Diluted Average) (2024 - 2025)

Historic Shares Outstanding (Diluted Average) for NovaBay Pharmaceuticals (NBY) over the last 6 years, with Q3 2025 value amounting to $5.9 million.

  • NovaBay Pharmaceuticals' Shares Outstanding (Diluted Average) rose 40874.46% to $5.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.9 million, marking a year-over-year increase of 40874.46%. This contributed to the annual value of -$200.0 for FY2011, which is N/A changed from last year.
  • As of Q3 2025, NovaBay Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $5.9 million, which was up 40874.46% from $5.8 million recorded in Q2 2025.
  • In the past 5 years, NovaBay Pharmaceuticals' Shares Outstanding (Diluted Average) registered a high of $5.9 million during Q3 2025, and its lowest value of $120000.0 during Q1 2024.